Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ten03: Factor X for surgery in Factor X deficiency
2009-015086-31Phase 3Terminated
- Sponsor
- Bio Products Laboratory
- Start
- Mar 2010
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of coagulation factor X human in factor X deficiency (FXD), sponsored by Bio Products Laboratory. Primary endpoint: Blood loss during and after surgery. Started Mar 2010; status: terminated.
02
Drugs
coagulation factor X human
03
Conditions
factor X deficiency (FXD)
Beyond the preview
Go deeper on 2009-015086-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-015086-31.